Case Study: a leading pharma company achieves continuous multiple sclerosis CI monitoring with C5i

Continuous CI monitoring in multiple sclerosis

A leading pharma company in the neurology space partnered with C5i to navigate a shifting market trend for multiple sclerosis treatments. The challenge was to understand the competitive impact of new high-efficacy therapies and the launch of Ocrevus on existing oral agents and monoclonal antibodies to shape effective promotional strategies.

C5i implemented a comprehensive continuous competitive intelligence monitoring solution. This involved synthesizing and analyzing data from numerous sources, including clinical trials, financial reports, and market access news. The key deliverables were real-time news alerts, weekly newsletters, and in-depth quarterly reports. This provided the client with actionable insights that directly helped shape their strategic decisions in a highly dynamic market.